Johnson & Johnson Covid-19 vaccine study paused due to illness


Vaccine trial is paused this time by a U. S company. Johnson and Johnson study has 60,000 patients and it's been paused because of an unexplained illness and one of them. Joe Walk, is the company CFO and executive vice president and says illnesses are to be expected in clinical trials. It should really reassure the public that All scientific, medical and ethical protocols are being followed to the utmost degree. It was on mornings with Maria today on the Fox Business Network were still on the timeline for first quarter next year for potential approval on we're gonna let the science dictate how we proceed. Final stage testing of a drug made by AstraZeneca is also on hold is health officials investigative patient illness in that trial boxes?

Coming up next